<DOC>
	<DOCNO>NCT00634166</DOCNO>
	<brief_summary>The primary objective compare effectiveness treatment Sulfamylon® solution initial topical moist dress mesh autograft follow initial graft procedure prevent graft loss prospective cohort subject versus historical control group non-inferiority trial .</brief_summary>
	<brief_title>Prospective Evaluation Effects Topical Therapy With Sulfamylon® For 5 % Topical Solution Autograft Healing Subjects With Thermal Injuries Requiring Meshed Autografts : A Comparison Historical Control Group</brief_title>
	<detailed_description>This prospective , non-inferiority , multi-center , historically control , open label study evaluate effect topical therapy Sulfamylon® For 5 % Topical Solution autograft heal subject thermal injury require mesh autograft similar historic control population Sulfamylon® For 5 % Topical Solution mafenide acetate mafenide salt form use . Prospective subject meet entrance criterion receive Sulfamylon® solution topical antimicrobial treatment moist dressing follow initial mesh autograft procedure ( Day 1 ) . Sulfamylon® solution use every 6-8 hour , need , keep dress moist . The graft evaluate Days 5-7 , Days 12-14 Days 18-21 , unless subject discharge , dy , experience graft loss / regrafting initial mesh autograft prior Assessment 4 ( Days 18-21 ) .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Sulfadiazine</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<mesh_term>Mafenide</mesh_term>
	<mesh_term>Silver Sulfadiazine</mesh_term>
	<criteria>In order prospective subject eligible entry study : Subjects must thermal injury 2060 % TBSA require least one mesh autograft chest , abdomen , proximal upper low extremity follow surgical excision burn injury . Refer Supplement 20.3.2 : Lund Browder chart Subjects may male female , 3 month age old Females childbearing potential must negative urine pregnancy test upon admission agree avoid pregnancy throughout course study . Since population hospitalize duration study , agreement sexual abstinence appropriate trial . Those subject wish commit sexual abstinence duration study must agree avoid pregnancy use medically supervise method contraception ( hormonal contraception conjunction vaginal spermicide tubal ligation least 3 month prior study entry ) Subjects must willing able provide write informed consent . If subject unable provide write informed consent , subject 's legally acceptable representative may provide write informed consent accordance IRB/IEC , federal , state local regulation . Prospective subject exclude study follow reason : Nonthermal burn injury Inhalation injury result PaO2 /FIO2 ratio &lt; 300 mmHg one arterial blood gas first 48 hour postadmission Females currently pregnant breast feeding , intend become pregnant course study Subjects acute renal failure Subjects know systemic allergy sulfonamide sulfurcontaining medication Time interval burn injury excision graft great 7 day Grafting procedure conduct and/or evaluated outpatient basis Inability use mesh autograft part initial grafting procedure Inability use SS5 % initial prophylactic topical antimicrobial therapy mesh autograft Thermal burn injury less 20 % great 60 % TBSA Subjects participate clinical study involve investigational product , participate study within previous 30 day Subjects know glucose6phosphate dehydrogenase deficiency</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>thermal injury</keyword>
	<keyword>burn</keyword>
	<keyword>Burn Patients ( Subjects Thermal Injuries Requiring Meshed Autografts )</keyword>
</DOC>